The Feinstein Institutes for Medical Research comprise the research arm of Northwell Health. Feinstein is home to 50 research labs, 2,500 clinical research studies, and 5,000 professional and support staff.

During the past decade, Feinstein Institute for Medical Research conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 33 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 22 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Feinstein Institute for Medical Research" #1 sponsor was "Northwell Health" with 35 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 8 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored, "EMD Serono" with 4 trials sponsored and "Celgene" with 4 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Feinstein Institute for Medical Research" #1 collaborator was "Autoimmunity Centers of Excellence" with 5 trials as a collaborator, "Rho Federal Systems Division, Inc." with 4 trials as a collaborator, "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 3 trials as a collaborator, "Feinstein Institute for Medical Research" with 2 trials as a collaborator and "GlaxoSmithKline" with 2 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Feinstein Institute for Medical Research" are "Systemic Lupus Erythematosus" (20 trials), "Lupus Erythematosus, Systemic" (12 trials), "Lupus Nephritis" (10 trials), "Stroke" (8 trials) and "Chronic Lymphocytic Leukemia" (4 trials). Many other conditions were trialed in "Feinstein Institute for Medical Research" in a lesser frequency.

Most popular intervention types in "Feinstein Institute for Medical Research" are "Drug" (44 trials), "Device" (19 trials), "Other" (12 trials), "Biological" (9 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Atacicept 150 mg" (3 trials), "Prednisone" (3 trials), "Atacicept 75 mg" (2 trials) and "Baricitinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Feinstein Institute for Medical Research" are 93 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Feinstein Institute for Medical Research". undefined are not yet recruiting, 14 are recruiting, 8 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 46 completed trials in Feinstein Institute for Medical Research, 1 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Feinstein Institute for Medical Research, 7 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 14 trials that are defined as “Not Applicable".